ERBB2 and posterior cortical atrophy: Given these considerations, we investigated whether expression of HER-2 was associated with a poor clinicopathological outcome, a high biochemical recurrence (BCR) rate, and short BCR-free survival in patients with localized PCa treated by radical prostatectomy (RP).